JP2010524984A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524984A5
JP2010524984A5 JP2010504490A JP2010504490A JP2010524984A5 JP 2010524984 A5 JP2010524984 A5 JP 2010524984A5 JP 2010504490 A JP2010504490 A JP 2010504490A JP 2010504490 A JP2010504490 A JP 2010504490A JP 2010524984 A5 JP2010524984 A5 JP 2010524984A5
Authority
JP
Japan
Prior art keywords
oxo
carbonyl
ethoxy
piperazine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524984A (ja
JP5309131B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/002790 external-priority patent/WO2008128647A1/en
Publication of JP2010524984A publication Critical patent/JP2010524984A/ja
Publication of JP2010524984A5 publication Critical patent/JP2010524984A5/ja
Application granted granted Critical
Publication of JP5309131B2 publication Critical patent/JP5309131B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504490A 2007-04-23 2008-04-09 P2y12アンタゴニストとしてのキノリン−カルボキサミド誘導体 Expired - Fee Related JP5309131B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07008209 2007-04-23
EP07008209.4 2007-04-23
PCT/EP2008/002790 WO2008128647A1 (en) 2007-04-23 2008-04-09 Quinoline-carboxamide derivatives as p2y12 antagonists

Publications (3)

Publication Number Publication Date
JP2010524984A JP2010524984A (ja) 2010-07-22
JP2010524984A5 true JP2010524984A5 (enExample) 2011-05-12
JP5309131B2 JP5309131B2 (ja) 2013-10-09

Family

ID=38462433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504490A Expired - Fee Related JP5309131B2 (ja) 2007-04-23 2008-04-09 P2y12アンタゴニストとしてのキノリン−カルボキサミド誘導体

Country Status (18)

Country Link
US (1) US8669266B2 (enExample)
EP (1) EP2148871A1 (enExample)
JP (1) JP5309131B2 (enExample)
KR (1) KR20100015886A (enExample)
CN (1) CN101663293B (enExample)
AR (1) AR066225A1 (enExample)
AU (1) AU2008241091B2 (enExample)
BR (1) BRPI0810462A2 (enExample)
CA (1) CA2684644A1 (enExample)
CL (1) CL2008001157A1 (enExample)
IL (1) IL201620A (enExample)
MX (1) MX2009011089A (enExample)
MY (1) MY153427A (enExample)
PA (1) PA8777901A1 (enExample)
PE (1) PE20090241A1 (enExample)
TW (1) TW200848042A (enExample)
UY (1) UY31039A1 (enExample)
WO (1) WO2008128647A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002235694B2 (en) 2001-02-28 2007-06-14 Covalon Technologies Inc. Method of making anti-microbial polymeric surfaces
US8288371B2 (en) 2007-10-05 2012-10-16 Pharmacopeia, Llc Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
BRPI0819696B1 (pt) 2007-11-29 2018-10-23 Actelion Pharmaceuticals Ltd compostos de derivados de 2-fenil-pirimidina, composição farmacêutica e uso de um composto
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
RU2401831C2 (ru) * 2008-12-15 2010-10-20 Алла Хем, Ллс Средство, снижающее влечение к алкоголю, фармацевтическая композиция и способы ее получения, лекарственное средство и способ лечения
WO2010116328A2 (en) 2009-04-08 2010-10-14 Actelion Pharmaceuticals Ltd 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
KR101728180B1 (ko) 2009-04-22 2017-04-18 액테리온 파마슈티칼 리미티드 티아졸 유도체들 및 p2y12 수용체 길항제로서 이들의 용도
WO2011024933A1 (ja) 2009-08-28 2011-03-03 第一三共株式会社 3-(ビアリールオキシ)プロピオン酸誘導体
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
WO2012122011A2 (en) 2011-03-04 2012-09-13 Glaxosmithkline Llc Amino-quinolines as kinase inhibitors
TWI547494B (zh) 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之胺基喹唑啉類
US9539246B2 (en) 2011-08-30 2017-01-10 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
CN102584852B (zh) * 2011-12-30 2014-08-13 厦门大学 真菌代谢产物桥南霉素及其制备方法和应用
TWI592417B (zh) 2012-09-13 2017-07-21 葛蘭素史克智慧財產發展有限公司 胺基喹唑啉激酶抑制劑之前藥
TW201425307A (zh) 2012-09-13 2014-07-01 Glaxosmithkline Llc 作為激酶抑制劑之胺基-喹啉類
EP2725025A1 (fr) * 2012-10-26 2014-04-30 Sanofi Dérives de 1H-indole-3-carboxamide et leurs utilisation comme antagonistes du P2Y12
TWI630203B (zh) 2013-02-21 2018-07-21 葛蘭素史克智慧財產發展有限公司 做為激酶抑制劑的喹唑啉類
CN104109158A (zh) * 2013-04-16 2014-10-22 上海医药工业研究院 一种纯化利伐沙班的方法
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
DE102015217396B4 (de) 2014-09-11 2018-07-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. System, insbesondere System zur Eingabesteuerung für eine Arbeitshilfe
CN106496249B (zh) * 2015-09-07 2019-12-13 江苏恒瑞医药股份有限公司 噁唑并吲哚类衍生物、其制备方法及其在医药上的应用
US10730868B2 (en) * 2016-07-14 2020-08-04 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
HUE057772T2 (hu) 2016-09-22 2022-06-28 Idorsia Pharmaceuticals Ltd Kristályos formák
US11179390B2 (en) 2017-03-15 2021-11-23 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a P2Y12 receptor antagonist
CN107648607A (zh) * 2017-09-11 2018-02-02 南昌大学 嘌呤2y12受体拮抗剂在制备糖尿病神经病理损伤疾病药物中的应用
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
WO2023108363A1 (en) * 2021-12-13 2023-06-22 Beijing Honghui Meditech Co., Ltd Pyrimidine-annulated triazole derivatives and their use in platelet aggregation inhibition
CN115429874A (zh) * 2022-09-20 2022-12-06 暨南大学 水蛭素靶向并抑制dpp4治疗糖尿病

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
WO2000077027A2 (en) 1999-06-14 2000-12-21 Tularik Limited Serine protease inhibitors
PT1094816E (pt) 1998-07-06 2009-03-10 Bristol Myers Squibb Co Sulfonamidas bifenílicas duplamente antagonistas receptores de angiotensina e endotelina
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6861424B2 (en) * 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
EP1427415B1 (en) 2001-09-21 2009-08-12 Brystol-Myers Squibb Company Lactam-containing compounds and derivatives thereof as factor xa inhibitors
CA2507657C (en) * 2002-12-11 2011-05-31 Bayer Schering Pharma Aktiengesellschaft 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
US7488739B2 (en) 2003-07-24 2009-02-10 Astellas Pharma Inc. Quinolone derivative or salt thereof
US7157445B2 (en) * 2004-02-26 2007-01-02 Aventis Pharma S.A. Administration of enoxaparin sodium to patients with severe renal impairment
JP2008094720A (ja) 2005-01-20 2008-04-24 Astellas Pharma Inc キノロン誘導体のプロドラッグ又はその塩
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
MX2008002363A (es) * 2005-08-17 2008-03-18 Schering Corp Ligandos novedosos de cinasa basados en quinolina de alta afinidad.

Similar Documents

Publication Publication Date Title
US10988478B1 (en) Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
CN115551867B (zh) 稠合三环类化合物、其药物组合物及用途
CA2566108C (en) Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
JP5309131B2 (ja) P2y12アンタゴニストとしてのキノリン−カルボキサミド誘導体
CA2787291C (en) 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
KR20220004100A (ko) 안드로겐 수용체를 표적 분해하는 이중 기능성의 키메라 헤테로 고리 화합물 및 이의 용도
KR20220022114A (ko) 헌팅턴병 치료 화합물
JP2007537231A5 (enExample)
JP2015522002A5 (enExample)
SG183218A1 (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EP2491038A1 (en) Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
CN106715419A (zh) 用作tank‑结合激酶抑制剂化合物的氨基三嗪衍生物
KR20100066492A (ko) C형 간염 치료용 화합물
CN111655695A (zh) 作为pde1抑制剂的取代的呋喃并嘧啶化合物
AU2019286312B2 (en) New isoxazolyl ether derivatives as GABA A alpha5 PAM
KR20230107291A (ko) PPARγ 조절제 및 사용 방법
CN121532385A (zh) 作为smarca2的选择性降解剂的双官能吖嗪缀合物及其治疗用途
CN1968949B (zh) 脯氨酸衍生物和其作为二肽基肽酶iv抑制剂的用途
DK2534151T3 (en) 8-methyl-1-phenyl-imidazo [1,5-a] pyrazin-COMPOUNDS
RU2800160C2 (ru) Новые производные простого эфира изоксазолила в качестве пам гамк a альфа5
US20260055095A1 (en) Novel compounds and uses thereof
WO2025210407A1 (en) (7-{1h,2h,3h-pyrido [2,3-b][1,4]oxazin-7-yl}-5h,6h,7h,8h-pyrido[3,4-d]pyrimidin-2-yl)amine derivatives as bifunctional degraders of hpk1 for the treatment of cancer
KR20230164602A (ko) 다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도
AU2011212453B2 (en) 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds